We are live on ! Find out more
GEA

Glen Eagle Advisors Portfolio holdings

AUM $714M
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+18.87%
3 Year Est. Return
+62.99%
5 Year Est. Return
+76.32%
10 Year Est. Return
AUM
$322M
AUM Growth
+$35.3M
Cap. Flow
+$17M
Cap. Flow %
5.28%
Top 10 Hldgs %
30.83%
Holding
1,070
New
67
Increased
247
Reduced
122
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 12.22%
2 Healthcare 10.01%
3 Financials 6.51%
4 Consumer Discretionary 4.83%
5 Communication Services 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIRT icon
751
Virtu Financial
VIRT
$5.19B
$7.46K ﹤0.01%
270
+143
+113% +$4.25K
RES icon
752
RPC Inc
RES
$1.3B
$7.42K ﹤0.01%
1,500
ORI icon
753
Old Republic International
ORI
$10.1B
$7.38K ﹤0.01%
296
+2
+0.7% +$50
TSN icon
754
Tyson Foods
TSN
$20B
$7.38K ﹤0.01%
100
EIX icon
755
Edison International
EIX
$30.6B
$7.23K ﹤0.01%
125
-167
-57% -$9.71K
KPTI icon
756
Karyopharm Therapeutics
KPTI
$161M
$7.22K ﹤0.01%
47
-7
-13% -$1.02K
RYN icon
757
Rayonier
RYN
$6.41B
$7.19K ﹤0.01%
220
SUM
758
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$6.97K ﹤0.01%
203
IWN icon
759
iShares Russell 2000 Value ETF
IWN
$14.3B
$6.96K ﹤0.01%
42
GNTX icon
760
Gentex
GNTX
$5.07B
$6.88K ﹤0.01%
208
+1
+0.5% +$35
DAUG icon
761
FT Vest US Equity Deep Buffer ETF August
DAUG
$367M
$6.88K ﹤0.01%
200
HOG icon
762
Harley-Davidson
HOG
$2.79B
$6.87K ﹤0.01%
150
AVXL icon
763
Anavex Life Sciences
AVXL
$230M
$6.86K ﹤0.01%
300
CMS icon
764
CMS Energy
CMS
$22.9B
$6.85K ﹤0.01%
116
-194
-63% -$12.1K
SNAP icon
765
Snap
SNAP
$7.42B
$6.81K ﹤0.01%
100
ETN icon
766
Eaton
ETN
$161B
$6.78K ﹤0.01%
46
+1
+2% +$144
PKW icon
767
Invesco BuyBack Achievers ETF
PKW
$1.68B
$6.77K ﹤0.01%
75
NIO icon
768
NIO
NIO
$11.6B
$6.65K ﹤0.01%
125
INTT icon
769
inTEST
INTT
$185M
$6.62K ﹤0.01%
+395
New +$5.33K
ACGL icon
770
Arch Capital
ACGL
$35B
$6.62K ﹤0.01%
170
PSX icon
771
Phillips 66
PSX
$83B
$6.61K ﹤0.01%
77
YORW icon
772
York Water
YORW
$503M
$6.57K ﹤0.01%
145
+10
+7% +$496
ARQT icon
773
Arcutis Biotherapeutics
ARQT
$3.42B
$6.55K ﹤0.01%
+240
New +$6.76K
BOTZ icon
774
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.2B
$6.47K ﹤0.01%
185
CEVA icon
775
CEVA Inc
CEVA
$1.08B
$6.39K ﹤0.01%
135
+35
+35% +$1.73K

Similar funds

Glen Eagle Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Glen Eagle Advisors held 1,070 positions worth $322M, up 12% from $286M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Glen Eagle Advisors deployed $17M of net new capital in Q2 2021, opening 67 new positions and adding to 247 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 10,640 shares worth $287K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares AAA-A Rated Corporate Bond ETF, an estimated $3.37M trimmed.

  • Glen Eagle Advisors's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 10,640 shares worth $287K.
  • Glen Eagle Advisors added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $2.53M increase.
  • Glen Eagle Advisors's biggest Q2 2021 reduction was iShares AAA-A Rated Corporate Bond ETF, cutting an estimated $3.37M.
  • Glen Eagle Advisors fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $26.9K.
  • Glen Eagle Advisors's ten largest holdings make up 31% of its $322M portfolio in Q2 2021.
  • Glen Eagle Advisors opened 67 new positions and closed 30 in Q2 2021.
  • Glen Eagle Advisors's portfolio value rose 12% quarter-over-quarter to $322M.

Based on Glen Eagle Advisors's 13F filing for Q2 2021, filed 13 Aug 2024.